Jeffrey Alan Jones

Insider Reports History

Entity
Individual
Location
One Main Street, Suite 520, Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Alan Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Chief Medical Officer Common Stock 114K $1.3M $11.41 Dec 18, 2024 Direct
Cullinan Oncology, Inc. Chief Medical Officer Stock Option (Right to Buy) 125K Feb 22, 2024 Direct

Insider Reports Filed by Jeffrey Alan Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Therapeutics, Inc. Dec 18, 2024 1 -$52.9K 4 Dec 20, 2024 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Feb 22, 2024 2 $0 4 Feb 23, 2024 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Dec 21, 2023 1 -$15.8K 4 Dec 22, 2023 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Dec 18, 2023 1 -$3.17K 4 Dec 20, 2023 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Jun 20, 2023 1 -$5.01K 4 Jun 21, 2023 Chief Medical Officer
CGEM Cullinan Oncology, Inc. May 18, 2023 1 -$3.45K 4 May 19, 2023 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Apr 18, 2023 1 -$4.2K 4 Apr 20, 2023 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Mar 20, 2023 1 -$4.41K 4 Mar 27, 2023 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Feb 17, 2023 2 $0 4 Feb 21, 2023 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Feb 28, 2022 1 $0 4 Mar 2, 2022 Chief Medical Officer
CGEM Cullinan Oncology, Inc. Feb 28, 2022 0 $0 3 Mar 2, 2022 Chief Medical Officer